The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the approval of the first over-the-counter (OTC) medicine to treat the symptoms of benign prostatic hyperplasia (BPH) in men, to be available through pharmacies without a prescription. An estimated one-in-four men over...